Al. Miller et al., LIGHT AND HEAVY LYSOSOMES - CHARACTERIZATION OF N-ACETYL-BETA-D-HEXOSAMINIDASE ISOLATED FROM NORMAL AND I-CELL DISEASE LYMPHOBLASTS, Glycobiology, 3(4), 1993, pp. 313-318
We previously reported that I-cell disease lymphoblasts maintain norma
l or near-normal intracellular levels of lysosomal enzymes, even thoug
h N-acetylglucosamine-1-phosphotransferase activity is severely depres
sed or absent (Little et al., Biochem. J., 248, 151-159, 1987). The pr
esent study, employing subcellular fractionation on colloidal silica g
radients, indicates that both light and heavy lysosomes isolated from
I-cell disease and pseudo-Hurler polydystrophy lymphoblasts possess no
rmal specific activity levels of N-acetyl-beta-D-hexosaminidase, alpha
-D-mannosidase and beta-D-glucuronidase. These current findings are in
contrast to those of cultured fibroblasts from the same patients, whe
re decreased intralysosomal enzyme activities are found. Column chroma
tography on Ricinus communis revealed that N-acetyl-beta-D-hexosaminid
ase in both heavy and fight I-cell disease lysosomal fractions from ly
mphoblasts possesses an increased number of accessible galactose resid
ues (30-50%) as compared to the enzyme from the corresponding normal c
ontrols. Endo-beta-N-acetylglucosaminidase H treatment of N-acetyl-bet
a-D-hexosaminidase from the I-cell lysosomal fractions suggests that t
he majority of newly synthesized high-mannose-type oligosaccharide cha
ins are modified to complex-type carbohydrates prior to being transpor
ted to lysosomes. This result from lymphoblasts differs from previous
findings with fibroblasts, where N-acetyl-beta-D-hexosaminidase from I
-cell disease and pseudo-Hurler polydystrophy lysosomes exhibited prop
erties associated with predominantly high-mannose-type oligosaccharide
chains. The current results imply that different cell types may modif
y the carbohydrate side chains of lysosomal enzymes in a differential
manner, and that selected cell types may also employ mechanisms other
than the mannose-6-phosphate pathway for targeting lysosomal enzymes t
o lysosomes.